Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Sohns

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BMC Proceedings|May 10, 2008
Case-control studies with affected sibshipsKarola Köhler, Melanie Sohns, Heike Bickeböller
BMC Proceedings|December 19, 2009
Integration of a priori gene set information into genome-wide association studiesMelanie Sohns, Albert Rosenberger, Heike Bickeböller
Pain Research & Management|May 1, 2020
Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly-A Subgroup Analysis of Routine Clinical Practice DataAndreas Schwittay, Melanie Sohns, Birgit Heckes, et al.
Current Medical Research and Opinion|September 12, 2018
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trialsBernd Lange, Melanie Sohns, José Tempero, et al.
Journal of Opioid Management|March 12, 2019
Tapentadol immediate release for moderate to severe acute post-surgery painEugene R Viscusi, René Allard, Melanie Sohns, et al.
Pain Management|January 25, 2020
Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of lifeKai-Uwe Kern, Melanie Sohns, Birgit Heckes, et al.
Journal of Pain Research|December 14, 2020
Tapentadol Prolonged Release for Long-Term Treatment of Pain in ChildrenRichard F Howard, Tatjana Radic, Melanie Sohns, et al.
Advances in Therapy|December 23, 2017
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting AnalgesicAriane Stollenwerk, Melanie Sohns, Fabian Heisig, et al.
Journal of Pain Research|February 5, 2021
Outcomes of the Pediatric Development Plan of TapentadolMariëlle Eerdekens, Tatjana Radic, Melanie Sohns, et al.
Genetic Epidemiology|November 20, 2009
Inclusion of a priori information in genome-wide association analysisNathan Tintle, Francesca Lantieri, Jérémie Lebrec, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BMC Proceedings|May 10, 2008
Case-control studies with affected sibshipsKarola Köhler, Melanie Sohns, Heike Bickeböller
BMC Proceedings|December 19, 2009
Integration of a priori gene set information into genome-wide association studiesMelanie Sohns, Albert Rosenberger, Heike Bickeböller
Pain Research & Management|May 1, 2020
Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly-A Subgroup Analysis of Routine Clinical Practice DataAndreas Schwittay, Melanie Sohns, Birgit Heckes, et al.
Current Medical Research and Opinion|September 12, 2018
Efficacy and safety of tapentadol prolonged release formulation in the treatment of elderly patients with moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo-, and active-controlled trialsBernd Lange, Melanie Sohns, José Tempero, et al.
Journal of Opioid Management|March 12, 2019
Tapentadol immediate release for moderate to severe acute post-surgery painEugene R Viscusi, René Allard, Melanie Sohns, et al.
Pain Management|January 25, 2020
Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of lifeKai-Uwe Kern, Melanie Sohns, Birgit Heckes, et al.
Journal of Pain Research|December 14, 2020
Tapentadol Prolonged Release for Long-Term Treatment of Pain in ChildrenRichard F Howard, Tatjana Radic, Melanie Sohns, et al.
Advances in Therapy|December 23, 2017
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting AnalgesicAriane Stollenwerk, Melanie Sohns, Fabian Heisig, et al.
Journal of Pain Research|February 5, 2021
Outcomes of the Pediatric Development Plan of TapentadolMariëlle Eerdekens, Tatjana Radic, Melanie Sohns, et al.
Genetic Epidemiology|November 20, 2009
Inclusion of a priori information in genome-wide association analysisNathan Tintle, Francesca Lantieri, Jérémie Lebrec, et al.
Pageof 2